Detalles de la búsqueda
1.
Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography.
Eur Heart J
; 2024 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38606889
2.
Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial.
Circulation
; 147(25): 1891-1901, 2023 06 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37154020
3.
Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 Trial.
Arterioscler Thromb Vasc Biol
; 43(8): 1572-1582, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37381988
4.
Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PAD.
Circulation
; 144(23): 1831-1841, 2021 12 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34637332
5.
Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial.
Am Heart J
; 246: 136-143, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34986394
6.
LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody MEDI5884 in Patients With Stable Coronary Artery Disease.
Arterioscler Thromb Vasc Biol
; 41(12): 3005-3014, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34706556
7.
Improvement in walking impairment following surgical and endovascular revascularization: Insights from VOYAGER PAD.
Vasc Med
; 27(4): 343-349, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35467452
8.
Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial.
Eur Heart J
; 42(39): 4040-4048, 2021 10 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34430972
9.
Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study.
Am Heart J
; 235: 12-23, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33577800
10.
Impact of chronic kidney disease on hemoglobin among patients with peripheral artery disease treated with P2Y12 inhibitors: Insights from the EUCLID trial.
Vasc Med
; 26(6): 608-612, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34082620
11.
Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD.
Circulation
; 149(19): 1536-1539, 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38709838
12.
Sex differences in guideline-directed medical therapy in 2021-22 among patients with peripheral artery disease.
Vasc Med
; 28(3): 233-235, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36847166
13.
An open-label, randomized bioavailability study with alternative methods of administration of crushed ticagrelor tablets in healthy volunteers.
Int J Clin Pharmacol Ther
; 53(2): 182-9, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25500486
14.
Low absolute risk of thrombotic and cardiovascular events in outpatient pregnant women with COVID-19.
Thromb Res
; 237: 209-215, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38677791
15.
Relationships of coronary heart disease with 27-hydroxycholesterol, low-density lipoprotein cholesterol, and menopausal hormone therapy.
Circulation
; 126(13): 1577-86, 2012 Sep 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-22932256
16.
Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.
JAMA
; 310(13): 1353-68, 2013 Oct 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-24084921
17.
Antithrombotic Prophylaxis with Rivaroxaban in Patients with Prehospital COVID-19: A Meta-analysis of Two Placebo-Controlled Trials.
Thromb Haemost
; 2023 Dec 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37995748
18.
Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions.
J Cardiovasc Dev Dis
; 10(4)2023 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37103043
19.
Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Rationale and methodology of the CORONA-VTE-Network study.
Thromb Res
; 228: 94-104, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37302267
20.
Estrogen receptor polymorphisms and the vascular effects of hormone therapy.
Arterioscler Thromb Vasc Biol
; 31(2): 464-9, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21106950